NVO - Novo Nordisk to spend $4.1B to build new plant for obesity drugs in N.C.
2024-06-24 14:51:58 ET
More on Novo Nordisk
- Novo Nordisk: Leading The Fight Against Diabetes And Obesity
- Novo Nordisk: The Market Is Right, Don't Fight Against It
- Novo Nordisk: Not The Best Investment Right Now, But A Great Case Study
- Lilly, Novo Nordisk to dominate weight loss therapy market: SA Investing Summit
- GLP-1 drugs linked to reduced dementia risk: study